Supported Assets

Syndax Pharmaceuticals

Soon

$8.72

-over selected period

$0.00 (0.00%)since US close

Onchain price
$8.72
Last close
$8.72Yahoo Finance ยท
Premium / discount
-

Price differences before fees and execution costs. Compare prices

Open Mo

About Syndax Pharmaceuticals

A commercial-stage biopharmaceutical company advancing cancer therapies, including its approved medicines Revuforj (revumenib) and Niktimvo (axatilimab-csfr), alongside clinical development programs.

Token

Token
SNDXc
Shares per token
1.00000000 SNDX